SCHEMBL13301593

SCHEMBL13301593

c1ccc(N(c2ccccc2)c2ccc3c(c2)c2cc(N(c4ccccc4)c4ccccc4)ccc2n3-c2ccc3c(c2)c2cc(N(c4ccccc4)c4ccccc4)ccc2n3-c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.46
L3MBTL1 Q9Y468 5/20 0.46
ATM Q13315 2/20 0.46
MAPT P10636 4/20 0.37
ALDH1A1 P00352 4/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
GAA P10253 1/20 0.36
GFER P55789 1/20 0.36
HPGD P15428 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
HTT P42858 2/20 0.35
LMNA P02545 2/20 0.35
MEN1 O00255 5/20 0.35
KMT2A Q03164 5/20 0.35
HSD17B10 Q99714 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3331856 0.95 KDM4E (0.55) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL13301588 0.95 KDM4E (0.55) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL15730706 0.95 KDM4E (0.55) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL19485347 0.95 KDM4E (0.55) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL13301594 0.95 KDM4E (0.55) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL1144158 0.95 KDM4E (0.50) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL12856945 0.95 KDM4E (0.50) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL13301590 0.95 KDM4E (0.50) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL19429316 0.95 KDM4E (0.50) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL9912865 0.95 L3MBTL1 (0.45) KDM4EL3MBTL1ATMMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100145067-A1 NOVEL CARBAZOLES DERIVATIVE AND USE THEREOF BANDO CHEMICAL INDUSTRIES, LTD. (JP) 2010-06-10 US disclosed
US-20100145067-A1 NOVEL CARBAZOLES DERIVATIVE AND USE THEREOF BANDO CHEMICAL INDUSTRIES, LTD. (JP) 2010-06-10 US disclosed
EP-2100880-A1 NOVEL CARBAZOLE DERIVATIVE AND USE THEREOF Bando Chemical Industries, Ltd. (JP) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100145067-A1 NOVEL CARBAZOLES DERIVATIVE AND USE THEREOF GDI2, SGK2, GDI1 KDM4E 1016/4885L3MBTL1 3298/4885ATM 1735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.